About this event
Age-related Macular Degeneration (AMD) remains one of the most challenging retinal diseases, particularly in its early and intermediate forms, where therapeutic options remain limited. In this exclusive satellite symposium recorded at Euretina 2025 in Paris, leading experts explore the growing body of evidence surrounding mitochondrial dysfunction in AMD and the potential of photobiomodulation (PBM) to modulate disease progression.
- Prof. Enrico Borrelli outlines the link between mitochondrial dysfunction and AMD and how PBM can improve mitochondrial activity.
- Prof. Sibel Demirel presents the eye-light® LM™ Low-level Light Therapy platform, explaining the protocol, clinical workflow, and patient selection.
- Dr. Claudio Iovino shares 12-month results from the randomized LightWave I Study, showing significant anatomical and functional benefits.
A concise, evidence-based update for retinal specialists exploring new approaches in AMD management.
The event will be followed by a LIVE Q&A session with Espansione's Medical Affairs Team.
Can't join the live session? Sign up anyway, we'll send you the replay!
Espansione Group
Science OnwardEspansione Group is a pioneering company in the field of photobiomodulation in ophthalmology and beyond.
